Cabometyx and Back disorder - a phase IV clinical study of FDA data

Summary:

Back disorder is reported as a side effect among people who take Cabometyx (cabozantinib s-malate), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Vitamin D3, and have Renal cell carcinoma.

The phase IV clinical study analyzes which people have Back disorder when taking Cabometyx. It is created by eHealthMe based on reports of 35,066 people who have side effects when taking Cabometyx from the FDA, and is updated regularly.

What is Cabometyx?

Cabometyx has active ingredients of cabozantinib s-malate. eHealthMe is studying from 35,069 Cabometyx users. Check the latest studies of Cabometyx.

What is Back disorder?

Back disorder is found to be associated with 1,033 drugs and 1,370 conditions by eHealthMe. Check the latest studies of Back disorder.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

35,066 people reported to have side effects when taking Cabometyx.
Among them, 48 people (0.14%) have Back disorder.

Among these 48 people:

How long have people been on Cabometyx when they have Back disorder? *

What is the gender of people who have Back disorder when taking Cabometyx? *

female: 21.74 %
male: 78.26 %

What is the age of people who have Back disorder when taking Cabometyx? *

What are other drugs people take besides Cabometyx? *

What are other side effects people have besides Back disorder? *

Fatigue (feeling of tiredness): 13 people, 27.08%
Diarrhea: 12 people, 25.00%
Nausea And Vomiting: 8 people, 16.67%
High Blood Pressure: 7 people, 14.58%
Thrombosis (formation of a blood clot inside a blood vessel): 6 people, 12.50%
Nausea (feeling of having an urge to vomit): 5 people, 10.42%
Weight Decreased: 4 people, 8.33%
Drug Hypersensitivity: 4 people, 8.33%
Liver Disorder (liver diseases): 4 people, 8.33%
Rashes (redness): 4 people, 8.33%

What are the existing conditions these people have? *

Renal Cell Carcinoma (a kidney cancer): 41 people, 85.42%
Prostate Cancer: 2 people, 4.17%
Neoplasm Malignant (cancer tumour): 2 people, 4.17%
Metastases To Bone (cancer spreads to bone): 2 people, 4.17%
Rickets (softening of bones): 1 person, 2.08%
Neuroendocrine Tumor: 1 person, 2.08%
Metastasis (spreadable cancer to other organ from origin): 1 person, 2.08%
Metastases To Lung (cancer spreads to lung): 1 person, 2.08%

* Approximation only. Some reports may have incomplete information.

Do you take Cabometyx and have Back disorder?

- Check whether Back disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cabometyx:

Cabometyx (35,069 reports)

Back disorder treatments and more:

Back disorder (23,781 reports)

Browse all side effects of Cabometyx:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Back disorder:

Back disorder (1,033 drugs)

Browse all the conditions that are associated with Back disorder:

Back disorder (1,370 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cabozantinib s-malate (the active ingredients of Cabometyx) and Cabometyx (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.